Use of HIV postexposure prophylaxis in healthcare workers after occupational exposure : A thai university hospital setting
PostExposure Prophylaxis (PEP) is widely used after exposures to Human Immunodeficiency Virus (HIV) to reduce the risk of infection in the healthcare setting. Few data are available on the safety and tolerability of Anti Retro Viral drugs (ARV) among Health Care Workers (HCWs) who are prescribed pro...
Gespeichert in:
| Veröffentlicht in: | Journal of the Medical Association of Thailand 2006-07, Vol.89 (7), p.974-978 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 978 |
|---|---|
| container_issue | 7 |
| container_start_page | 974 |
| container_title | Journal of the Medical Association of Thailand |
| container_volume | 89 |
| creator | KIERTIBURANAKUL, Sasisopin WANNAYING, Bunchong TONSUTTAKUL, Sirirat KEHACHINDAWAT, Pranee APIVANICH, Siriluk SOMSAKUL, Somporn MALATHUM, Kumthorn |
| description | PostExposure Prophylaxis (PEP) is widely used after exposures to Human Immunodeficiency Virus (HIV) to reduce the risk of infection in the healthcare setting. Few data are available on the safety and tolerability of Anti Retro Viral drugs (ARV) among Health Care Workers (HCWs) who are prescribed prophylaxis.
To collect information about the safety and compliance of taking ARV for HIV PEP among HCWs.
Retrospective review on registry data regarding occupational HIV exposures, the PEP regimens used, and the adverse events associated with PEP was performed.
During a five year-period, 820 episodes with occupational blood or body fluid exposures were reported Nurses (27%) were the largest group at risk. The most common type of exposure was percutaneous injuries (82%). Only 125 (15%) HCWs had occupational exposures to HIV, 64 HCWs were prescribed HIV PEP and 32 (50%) HCWs did not complete the PEP regimen as initially prescribed. The commonly prescribed ARV was zidovudine (38%), lamivudine (33%), and indinavir (11%). Overall, 18 (28%) HCWs reported symptoms while on PEP such as nausea (89%), vomiting (55%), and dizziness (39%). None of the HCWs had HIV seroconversion.
Adverse effects from HIV PEP were very common. Clinicians prescribing HIV PEP need to discuss with HCWs about PEP efficacy and side effects. Education efforts aimed at occupational exposure prevention are still important issues. |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pubmed_primary_16881429</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16881429</sourcerecordid><originalsourceid>FETCH-LOGICAL-p154t-67e18e4e6ce4c94f3228f8616866705d2648fc2453ed5d0c1658061c7696e1b3</originalsourceid><addsrcrecordid>eNpF0LFOwzAQBmAPIFoKr4C8MEayHdt12KoKaKVKLIW1cp0zMaSxZTvQ8PREosByN9x3J91_hqaEMlEwRtQEXab0RggXlSwv0IRKpShn1RR9PSfA3uLV-gUHnzIcx9pHwCH60AytPrqEXYcb0G1ujB4nnz6-Q0xY2wwRe2P6oLPznW7x3_YdXuDcaIf7zn2M2OUBNz4Fl0eVIGfXvV6hc6vbBNenPkPbh_vtclVsnh7Xy8WmCFTwXMg5UAUcpAFuKm5LxpRVcnxByjkRNZNcWcO4KKEWNTFUCkUkNXNZSaD7coZufs6Gfn-AeheiO-g47H4zGMHtCehkdGuj7oxL_05RIYWg5Td9_mZA</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Use of HIV postexposure prophylaxis in healthcare workers after occupational exposure : A thai university hospital setting</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>KIERTIBURANAKUL, Sasisopin ; WANNAYING, Bunchong ; TONSUTTAKUL, Sirirat ; KEHACHINDAWAT, Pranee ; APIVANICH, Siriluk ; SOMSAKUL, Somporn ; MALATHUM, Kumthorn</creator><creatorcontrib>KIERTIBURANAKUL, Sasisopin ; WANNAYING, Bunchong ; TONSUTTAKUL, Sirirat ; KEHACHINDAWAT, Pranee ; APIVANICH, Siriluk ; SOMSAKUL, Somporn ; MALATHUM, Kumthorn</creatorcontrib><description>PostExposure Prophylaxis (PEP) is widely used after exposures to Human Immunodeficiency Virus (HIV) to reduce the risk of infection in the healthcare setting. Few data are available on the safety and tolerability of Anti Retro Viral drugs (ARV) among Health Care Workers (HCWs) who are prescribed prophylaxis.
To collect information about the safety and compliance of taking ARV for HIV PEP among HCWs.
Retrospective review on registry data regarding occupational HIV exposures, the PEP regimens used, and the adverse events associated with PEP was performed.
During a five year-period, 820 episodes with occupational blood or body fluid exposures were reported Nurses (27%) were the largest group at risk. The most common type of exposure was percutaneous injuries (82%). Only 125 (15%) HCWs had occupational exposures to HIV, 64 HCWs were prescribed HIV PEP and 32 (50%) HCWs did not complete the PEP regimen as initially prescribed. The commonly prescribed ARV was zidovudine (38%), lamivudine (33%), and indinavir (11%). Overall, 18 (28%) HCWs reported symptoms while on PEP such as nausea (89%), vomiting (55%), and dizziness (39%). None of the HCWs had HIV seroconversion.
Adverse effects from HIV PEP were very common. Clinicians prescribing HIV PEP need to discuss with HCWs about PEP efficacy and side effects. Education efforts aimed at occupational exposure prevention are still important issues.</description><identifier>ISSN: 0125-2208</identifier><identifier>PMID: 16881429</identifier><identifier>CODEN: JMTHBU</identifier><language>eng</language><publisher>Bangkok: Medical Association of Thailand</publisher><subject>Anti-HIV Agents - administration & dosage ; Biological and medical sciences ; General aspects ; Health Personnel ; HIV Infections - prevention & control ; HIV Infections - transmission ; Hospitals, University ; Humans ; Infectious Disease Transmission, Patient-to-Professional - prevention & control ; Medical sciences ; Occupational Exposure ; Registries ; Retrospective Studies ; Risk Factors ; Thailand</subject><ispartof>Journal of the Medical Association of Thailand, 2006-07, Vol.89 (7), p.974-978</ispartof><rights>2006 INIST-CNRS</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18156551$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16881429$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KIERTIBURANAKUL, Sasisopin</creatorcontrib><creatorcontrib>WANNAYING, Bunchong</creatorcontrib><creatorcontrib>TONSUTTAKUL, Sirirat</creatorcontrib><creatorcontrib>KEHACHINDAWAT, Pranee</creatorcontrib><creatorcontrib>APIVANICH, Siriluk</creatorcontrib><creatorcontrib>SOMSAKUL, Somporn</creatorcontrib><creatorcontrib>MALATHUM, Kumthorn</creatorcontrib><title>Use of HIV postexposure prophylaxis in healthcare workers after occupational exposure : A thai university hospital setting</title><title>Journal of the Medical Association of Thailand</title><addtitle>J Med Assoc Thai</addtitle><description>PostExposure Prophylaxis (PEP) is widely used after exposures to Human Immunodeficiency Virus (HIV) to reduce the risk of infection in the healthcare setting. Few data are available on the safety and tolerability of Anti Retro Viral drugs (ARV) among Health Care Workers (HCWs) who are prescribed prophylaxis.
To collect information about the safety and compliance of taking ARV for HIV PEP among HCWs.
Retrospective review on registry data regarding occupational HIV exposures, the PEP regimens used, and the adverse events associated with PEP was performed.
During a five year-period, 820 episodes with occupational blood or body fluid exposures were reported Nurses (27%) were the largest group at risk. The most common type of exposure was percutaneous injuries (82%). Only 125 (15%) HCWs had occupational exposures to HIV, 64 HCWs were prescribed HIV PEP and 32 (50%) HCWs did not complete the PEP regimen as initially prescribed. The commonly prescribed ARV was zidovudine (38%), lamivudine (33%), and indinavir (11%). Overall, 18 (28%) HCWs reported symptoms while on PEP such as nausea (89%), vomiting (55%), and dizziness (39%). None of the HCWs had HIV seroconversion.
Adverse effects from HIV PEP were very common. Clinicians prescribing HIV PEP need to discuss with HCWs about PEP efficacy and side effects. Education efforts aimed at occupational exposure prevention are still important issues.</description><subject>Anti-HIV Agents - administration & dosage</subject><subject>Biological and medical sciences</subject><subject>General aspects</subject><subject>Health Personnel</subject><subject>HIV Infections - prevention & control</subject><subject>HIV Infections - transmission</subject><subject>Hospitals, University</subject><subject>Humans</subject><subject>Infectious Disease Transmission, Patient-to-Professional - prevention & control</subject><subject>Medical sciences</subject><subject>Occupational Exposure</subject><subject>Registries</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Thailand</subject><issn>0125-2208</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0LFOwzAQBmAPIFoKr4C8MEayHdt12KoKaKVKLIW1cp0zMaSxZTvQ8PREosByN9x3J91_hqaEMlEwRtQEXab0RggXlSwv0IRKpShn1RR9PSfA3uLV-gUHnzIcx9pHwCH60AytPrqEXYcb0G1ujB4nnz6-Q0xY2wwRe2P6oLPznW7x3_YdXuDcaIf7zn2M2OUBNz4Fl0eVIGfXvV6hc6vbBNenPkPbh_vtclVsnh7Xy8WmCFTwXMg5UAUcpAFuKm5LxpRVcnxByjkRNZNcWcO4KKEWNTFUCkUkNXNZSaD7coZufs6Gfn-AeheiO-g47H4zGMHtCehkdGuj7oxL_05RIYWg5Td9_mZA</recordid><startdate>200607</startdate><enddate>200607</enddate><creator>KIERTIBURANAKUL, Sasisopin</creator><creator>WANNAYING, Bunchong</creator><creator>TONSUTTAKUL, Sirirat</creator><creator>KEHACHINDAWAT, Pranee</creator><creator>APIVANICH, Siriluk</creator><creator>SOMSAKUL, Somporn</creator><creator>MALATHUM, Kumthorn</creator><general>Medical Association of Thailand</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200607</creationdate><title>Use of HIV postexposure prophylaxis in healthcare workers after occupational exposure : A thai university hospital setting</title><author>KIERTIBURANAKUL, Sasisopin ; WANNAYING, Bunchong ; TONSUTTAKUL, Sirirat ; KEHACHINDAWAT, Pranee ; APIVANICH, Siriluk ; SOMSAKUL, Somporn ; MALATHUM, Kumthorn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p154t-67e18e4e6ce4c94f3228f8616866705d2648fc2453ed5d0c1658061c7696e1b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Anti-HIV Agents - administration & dosage</topic><topic>Biological and medical sciences</topic><topic>General aspects</topic><topic>Health Personnel</topic><topic>HIV Infections - prevention & control</topic><topic>HIV Infections - transmission</topic><topic>Hospitals, University</topic><topic>Humans</topic><topic>Infectious Disease Transmission, Patient-to-Professional - prevention & control</topic><topic>Medical sciences</topic><topic>Occupational Exposure</topic><topic>Registries</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Thailand</topic><toplevel>online_resources</toplevel><creatorcontrib>KIERTIBURANAKUL, Sasisopin</creatorcontrib><creatorcontrib>WANNAYING, Bunchong</creatorcontrib><creatorcontrib>TONSUTTAKUL, Sirirat</creatorcontrib><creatorcontrib>KEHACHINDAWAT, Pranee</creatorcontrib><creatorcontrib>APIVANICH, Siriluk</creatorcontrib><creatorcontrib>SOMSAKUL, Somporn</creatorcontrib><creatorcontrib>MALATHUM, Kumthorn</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Journal of the Medical Association of Thailand</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KIERTIBURANAKUL, Sasisopin</au><au>WANNAYING, Bunchong</au><au>TONSUTTAKUL, Sirirat</au><au>KEHACHINDAWAT, Pranee</au><au>APIVANICH, Siriluk</au><au>SOMSAKUL, Somporn</au><au>MALATHUM, Kumthorn</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of HIV postexposure prophylaxis in healthcare workers after occupational exposure : A thai university hospital setting</atitle><jtitle>Journal of the Medical Association of Thailand</jtitle><addtitle>J Med Assoc Thai</addtitle><date>2006-07</date><risdate>2006</risdate><volume>89</volume><issue>7</issue><spage>974</spage><epage>978</epage><pages>974-978</pages><issn>0125-2208</issn><coden>JMTHBU</coden><abstract>PostExposure Prophylaxis (PEP) is widely used after exposures to Human Immunodeficiency Virus (HIV) to reduce the risk of infection in the healthcare setting. Few data are available on the safety and tolerability of Anti Retro Viral drugs (ARV) among Health Care Workers (HCWs) who are prescribed prophylaxis.
To collect information about the safety and compliance of taking ARV for HIV PEP among HCWs.
Retrospective review on registry data regarding occupational HIV exposures, the PEP regimens used, and the adverse events associated with PEP was performed.
During a five year-period, 820 episodes with occupational blood or body fluid exposures were reported Nurses (27%) were the largest group at risk. The most common type of exposure was percutaneous injuries (82%). Only 125 (15%) HCWs had occupational exposures to HIV, 64 HCWs were prescribed HIV PEP and 32 (50%) HCWs did not complete the PEP regimen as initially prescribed. The commonly prescribed ARV was zidovudine (38%), lamivudine (33%), and indinavir (11%). Overall, 18 (28%) HCWs reported symptoms while on PEP such as nausea (89%), vomiting (55%), and dizziness (39%). None of the HCWs had HIV seroconversion.
Adverse effects from HIV PEP were very common. Clinicians prescribing HIV PEP need to discuss with HCWs about PEP efficacy and side effects. Education efforts aimed at occupational exposure prevention are still important issues.</abstract><cop>Bangkok</cop><pub>Medical Association of Thailand</pub><pmid>16881429</pmid><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0125-2208 |
| ispartof | Journal of the Medical Association of Thailand, 2006-07, Vol.89 (7), p.974-978 |
| issn | 0125-2208 |
| language | eng |
| recordid | cdi_pubmed_primary_16881429 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Anti-HIV Agents - administration & dosage Biological and medical sciences General aspects Health Personnel HIV Infections - prevention & control HIV Infections - transmission Hospitals, University Humans Infectious Disease Transmission, Patient-to-Professional - prevention & control Medical sciences Occupational Exposure Registries Retrospective Studies Risk Factors Thailand |
| title | Use of HIV postexposure prophylaxis in healthcare workers after occupational exposure : A thai university hospital setting |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T15%3A16%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20HIV%20postexposure%20prophylaxis%20in%20healthcare%20workers%20after%20occupational%20exposure%20:%20A%20thai%20university%20hospital%20setting&rft.jtitle=Journal%20of%20the%20Medical%20Association%20of%20Thailand&rft.au=KIERTIBURANAKUL,%20Sasisopin&rft.date=2006-07&rft.volume=89&rft.issue=7&rft.spage=974&rft.epage=978&rft.pages=974-978&rft.issn=0125-2208&rft.coden=JMTHBU&rft_id=info:doi/&rft_dat=%3Cpubmed_pasca%3E16881429%3C/pubmed_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16881429&rfr_iscdi=true |